Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2008-03-26

Original market date: See footnote 1

1978-12-31

Product name:

TRAVASOL INJ WITHOUT ELECTROLYTES 8.5%

DIN:

00388750 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

14

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:20.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05BA01 AMINO ACIDS

Active ingredient group (AIG) number:See footnote5

1411693001

List of active ingredient(s)
Active ingredient(s) Strength
ARGININE 880 MG / 100 ML
DL-METHIONINE 492 MG / 100 ML
GLYCINE 1.76 G / 100 ML
HISTIDINE 372 MG / 100 ML
ISOLEUCINE 406 MG / 100 ML
L-ALANINE 1.76 G / 100 ML
L-LYSINE HYDROCHLORIDE 492 MG / 100 ML
LEUCINE 526 MG / 100 ML
PHENYLALANINE 526 MG / 100 ML
PROLINE 356 MG / 100 ML
THREONINE 356 MG / 100 ML
TRYPTOPHAN 152 MG / 100 ML
TYROSINE 34 MG / 100 ML
VALINE 390 MG / 100 ML
Version 4.0.2
Date modified: